Literature DB >> 28324200

Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement.

Andreina Manfredi1, Marco Sebastiani2, Stefania Cerri3, Giulia Cassone2, Pietrantonio Bellini4, Giovanni Della Casa5, Fabrizio Luppi3, Clodoveo Ferri2.   

Abstract

Primary Sjögren syndrome (pSS)-related interstitial lung disease (ILD) involved about 10-20% of patients. In 20% of cases, ILD can be diagnosed before pSS; anyway, few studies have investigated the frequency of ILD as the first clinically relevant manifestation of pSS, generally referred to retrospective studies. Aim of our prospective study was to describe prevalence, clinical, serological, and instrumental features of non-sicca onset pSS patients with interstitial lung involvement. During a period of 48 months, all consecutive patients diagnosed as pSS were enrolled. For all patients, the reason for the first visit was recorded. When present, ILD was categorized as definite, possible, or inconsistent with usual interstitial pneumonia (UIP) pattern, according to the current criteria. ILD was the main presenting symptom in 13/77 new diagnoses of pSS patients; in particular, 6/13 patients were initially diagnosed as idiopathic ILD, and only later developed clinical manifestations suggestive for pSS; ILD-pSS patients were older than others and showed a higher EULAR primary Sjögren's syndrome disease activity index. A radiologic definite or possible UIP pattern was detected in 12/13 pSS. For the first time, we prospectively observed a prevalence of 16.8% of non-sicca onset pSS patients with ILD. Interestingly, UIP pattern was the most frequently detected, while typical autoantibodies were often absent. These features stressed the importance of differential diagnosis in the first stage of the disease, considering the possible poorer prognosis in this subgroup of patients. Multidisciplinary approach is crucial for a correct and early diagnosis, at both onset and follow-up.

Entities:  

Keywords:  Interstitial lung disease; Minor salivary gland biopsy; Sjögren’s syndrome; Usual interstitial pneumonia

Mesh:

Year:  2017        PMID: 28324200     DOI: 10.1007/s10067-017-3601-1

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  38 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

Review 2.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

3.  [Reversed halo sign in organizing pneumonia secondary to Sjögren syndrome].

Authors:  Satoshi Anai; Hiroyuki Kumazoe; Kentarou Wakamatsu; Nobuhiko Nagata; Yoichi Nakanishi; Akira Kajiki
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2011-09

4.  2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative.

Authors:  Frank van den Hoogen; Dinesh Khanna; Jaap Fransen; Sindhu R Johnson; Murray Baron; Alan Tyndall; Marco Matucci-Cerinic; Raymond P Naden; Thomas A Medsger; Patricia E Carreira; Gabriela Riemekasten; Philip J Clements; Christopher P Denton; Oliver Distler; Yannick Allanore; Daniel E Furst; Armando Gabrielli; Maureen D Mayes; Jacob M van Laar; James R Seibold; Laszlo Czirjak; Virginia D Steen; Murat Inanc; Otylia Kowal-Bielecka; Ulf Müller-Ladner; Gabriele Valentini; Douglas J Veale; Madelon C Vonk; Ulrich A Walker; Lorinda Chung; David H Collier; Mary Ellen Csuka; Barri J Fessler; Serena Guiducci; Ariane Herrick; Vivien M Hsu; Sergio Jimenez; Bashar Kahaleh; Peter A Merkel; Stanislav Sierakowski; Richard M Silver; Robert W Simms; John Varga; Janet E Pope
Journal:  Arthritis Rheum       Date:  2013-10-03

5.  A longitudinal cohort study of Finnish patients with primary Sjögren's syndrome: clinical, immunological, and epidemiological aspects.

Authors:  M Pertovaara; E Pukkala; P Laippala; A Miettinen; A Pasternack
Journal:  Ann Rheum Dis       Date:  2001-05       Impact factor: 19.103

6.  Interstitial lung disease in primary Sjögren's syndrome.

Authors:  F Roca; S Dominique; J Schmidt; A Smail; P Duhaut; H Lévesque; I Marie
Journal:  Autoimmun Rev       Date:  2016-09-25       Impact factor: 9.754

Review 7.  Pulmonary manifestations of Sjögren's syndrome.

Authors:  George Stojan; Alan N Baer; Sonye K Danoff
Journal:  Curr Allergy Asthma Rep       Date:  2013-08       Impact factor: 4.806

Review 8.  Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature.

Authors:  Clodoveo Ferri; Andreina Manfredi; Marco Sebastiani; Michele Colaci; Dilia Giuggioli; Caterina Vacchi; Giovanni Della Casa; Stefania Cerri; Pietro Torricelli; Fabrizio Luppi
Journal:  Autoimmun Rev       Date:  2015-09-16       Impact factor: 9.754

9.  Bronchiolitis obliterans organizing pneumonia and Sjögren's syndrome.

Authors:  E L Matteson; R W Ike
Journal:  J Rheumatol       Date:  1990-05       Impact factor: 4.666

Review 10.  Aging and Immunopathology in Primary Sjögren's Syndrome.

Authors:  Hjalmar R Bouma; Hendrika Bootsma; Jolien F van Nimwegen; Erlin A Haacke; Fred K Spijkervet; Arjan Vissink; Frans G M Kroese
Journal:  Curr Aging Sci       Date:  2015
View more
  13 in total

1.  Sjogren's Syndrome and Pulmonary Disease.

Authors:  Ruben A Peredo; Scott Beegle
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Risk factors for progression of interstitial lung disease in Sjögren's syndrome: a single-centered, retrospective study.

Authors:  Shi-Hao He; Yu-Jie He; Kuang-Jin Guo; Xu Liang; Shan-Shan Li; Tian-Fang Li
Journal:  Clin Rheumatol       Date:  2021-11-10       Impact factor: 2.980

3.  A retrospective analysis of distinguishing features of chest HRCT and clinical manifestation in primary Sjögren's syndrome-related interstitial lung disease in a Chinese population.

Authors:  Xin Dong; Junfei Zhou; Xiaojuan Guo; Yifan Li; Yuetong Xu; Qiang Fu; Yong Lu; Yi Zheng
Journal:  Clin Rheumatol       Date:  2018-09-22       Impact factor: 2.980

Review 4.  Acute exacerbation of interstitial lung disease associated with rheumatic disease.

Authors:  Fabrizio Luppi; Marco Sebastiani; Carlo Salvarani; Elisabeth Bendstrup; Andreina Manfredi
Journal:  Nat Rev Rheumatol       Date:  2021-12-07       Impact factor: 20.543

Review 5.  Pulmonary Manifestations of Primary Sjögren's Syndrome: Underlying Immunological Mechanisms, Clinical Presentation, and Management.

Authors:  Sarthak Gupta; Marcela A Ferrada; Sarfaraz A Hasni
Journal:  Front Immunol       Date:  2019-06-12       Impact factor: 7.561

Review 6.  Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review.

Authors:  Caterina Vacchi; Marco Sebastiani; Giulia Cassone; Stefania Cerri; Giovanni Della Casa; Carlo Salvarani; Andreina Manfredi
Journal:  J Clin Med       Date:  2020-02-03       Impact factor: 4.241

Review 7.  Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications.

Authors:  Gian Luca Erre; Marco Sebastiani; Andreina Manfredi; Elisabetta Gerratana; Fabiola Atzeni; Giuseppe Passiu; Arduino A Mangoni
Journal:  Drugs Context       Date:  2021-01-15

Review 8.  Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease.

Authors:  Caterina Vacchi; Andreina Manfredi; Giulia Cassone; Gian Luca Erre; Carlo Salvarani; Marco Sebastiani
Journal:  Drugs Context       Date:  2021-01-15

Review 9.  Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential.

Authors:  Marco Sebastiani; Paola Faverio; Andreina Manfredi; Giulia Cassone; Caterina Vacchi; Anna Stainer; Maria Rosa Pozzi; Carlo Salvarani; Alberto Pesci; Fabrizio Luppi
Journal:  Biomedicines       Date:  2020-12-26

10.  Diagnosis, Clinical Features and Management of Interstitial Lung Diseases in Rheumatic Disorders: Still a Long Journey.

Authors:  Marco Sebastiani; Caterina Vacchi; Giulia Cassone; Andreina Manfredi
Journal:  J Clin Med       Date:  2022-01-14       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.